Calibrated from 23 weeks’ gestation to 18 years, BioScan touch i8 Nano uses bioelectrical impedance to estimate tissue composition and fluid distribution at the bedside, helping clinicians determine whether changes in weight reflect growth, nutritional status or fluid accumulation.
BioScan touch i8 Nano uses bioelectrical impedance analysis through surface electrodes. A low-level electrical signal passes through the body, while differences in fluid, lean tissue, fat and cell membranes generate resistance and reactance data. These raw measurements are used to derive phase angle and estimate tissue composition and body-water compartments.
Its key innovation is a dedicated calibration spanning 23 weeks’ gestation to 18 years, combined with Maltron’s fully integrated AI calibration system. The platform brings impedance-derived body composition, hydration, cellular indicators and age-related growth data together in one longitudinal assessment.
Explore three distinct clinical applications of BioScan touch i8 Nano:
Designed for rapid, repeatable assessment at the bedside:
Weight and BMI cannot distinguish fat, muscle and lean tissue from changes in hydration. BioScan touch i8 Nano adds objective body composition data to the assessment of growth and nutritional status.
This helps clinicians identify low tissue mass that may be masked by oedema, interpret weight change more accurately and follow the response to nutritional intervention over time.
Weight and fluid charts indicate net change but do not show how water is distributed between body compartments. BioScan touch i8 Nano provides a more detailed assessment of hydration and fluid distribution.
This additional information supports the assessment of oedema, dehydration and changing fluid status, and helps clinicians evaluate the response to fluid-related interventions.
In paediatric renal care, weight alone may not adequately define fluid overload or target fluid status. BioScan touch i8 Nano enables repeatable assessment before, during and after treatment.
This enables clinicians to assess the direction and magnitude of fluid change, compare treatment sessions and support more individualised fluid management.
For clinical evaluations, implementation support and product selection guidance..
SEND INQUIRY